Medicalgorithmics S.A.

WSE-MDG
Warsaw Stock Exchange NYSE
Healthcare Medical Devices
Global Rank
#27311
Country Rank
n/a
Market Cap
66.19 M
Price
6.65
Change (%)
1.76%
Volume
16,218

Medicalgorithmics S.A.'s latest marketcap:

66.19 M

As of 06/07/2025, Medicalgorithmics S.A.'s market capitalization has reached $66.19 M. According to our data, Medicalgorithmics S.A. is the 27311th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 66.19 M
Revenue (ttm) 6.28 M
Net Income (ttm) -4,303,496.56
Shares Out 9.95 M
EPS (ttm) 0
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 06/04/2025
Market Cap Chart
Data Updated: 06/07/2025

Medicalgorithmics S.A.'s yearly market capitalization.

Medicalgorithmics S.A. has seen its market value grow from zł98.24 M to zł250.31 M since 2020, representing a total increase of 154.79% and an annual compound growth rate (CAGR) of 23.47%.
Date Market Cap Change (%)
06/07/2025 zł250.31 M 52.37%
12/30/2024 zł168.2 M -44.68%
12/29/2023 zł304.06 M 149.18%
12/30/2022 zł122.02 M 29.46%
12/30/2021 zł94.25 M -4.06%
12/30/2020 zł98.24 M

Company Profile

About Medicalgorithmics S.A.

Medicalgorithmics S.A. is a leading provider of cardiac diagnostic solutions, operating in Poland, the United States, and internationally. The company specializes in innovative technologies for arrhythmia diagnosis and cardiovascular monitoring.

Key Products & Services

  • PocketECG: A comprehensive diagnostic solution for arrhythmia, offering full ECG signal disclosure, data analysis, and reporting.
  • DeepRhythmAI: AI-powered algorithms for advanced ECG analysis.
  • Virtual Cardiac Stress Test: An AI-based medical system designed to detect coronary artery atherosclerotic stenosis.
  • ECG TechBot: Software utilizing algorithms for automatic ECG signal analysis and interpretation (under development).
  • PatchECG: A single-channel offline monitoring device (under development).
  • NextGen: An upgraded software version for PocketECG (under development).

Additional Offerings

Medicalgorithmics also provides:

  • IT services for healthcare
  • ECG monitoring solutions
  • Scientific research and development services
  • Manufacturing of electrical medical equipment

Founded: 2005
Headquarters: Warsaw, Poland

Frequently Asked Questions

  • What is Medicalgorithmics S.A.'s (WSE-MDG) current market cap?
    As of 06/07/2025, Medicalgorithmics S.A. (including the parent company, if applicable) has an estimated market capitalization of $66.19 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Medicalgorithmics S.A. global market capitalization ranking is approximately 27311 as of 06/07/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking
Community

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.